Current perspectives on effective migraine treatments: Are small clinical differences important for patients?

Drugs of Today

Volumn 39, Issue SUPPL. D, 2003, Pages 37-41

  Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; ANTIMIGRAINE AGENT; ELETRIPTAN; NARATRIPTAN; RIZATRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST; SUMATRIPTAN; ZOLMITRIPTAN;

AVOIDANCE BEHAVIOR; CLINICAL TRIAL; CONFERENCE PAPER; DISABILITY; DISEASE SEVERITY; DRUG CHOICE; DRUG COST; DRUG EFFICACY; HUMAN; META ANALYSIS; METHODOLOGY; MIGRAINE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; RECURRENCE RISK; SIDE EFFECT;

CLINICAL TRIALS; HUMANS; META-ANALYSIS; MIGRAINE DISORDERS; RECEPTORS, SEROTONIN, 5-HT1; RESEARCH DESIGN; SEROTONIN AGONISTS;

EID: 1442349716     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Humphrey, P.P., Feniuk, W., Perren, M.J., Beresford, I.J., Skingle, M., Whalley, E.T. Serotonin and migraine. Ann N Y Acad Sci 1990, 600: 587-98; discussion 598-600.
2. Goadsby, P.J. The pharmacology of headache. Prog Neurobiol 2000, 62: 509-25.
3. Humphrey, P.P., Goadsby, P.J. The mode of action of sumatriptan is vascular? A debate. Cephalalgia 1994, 14: 401-10; discussion 393.
4. Song, F.A.D., Glenny, A.M., Deeks, J.J. Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. BMJ 2003, 326: 472.
5. Ferrari, M.D., Goadsby, P.J., Roon, K.I., Lipton, R.B. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: Detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002, 22: 633-58.
6. Ferrari, M.D., Roon, K.I., Lipton, R.B., Goadsby, P.J. Oral triptans (serotonin 5-HT (1B/1D) agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet 2001, 358: 1668-75.
7. Ferrari, M.D. Tripstar: A comprehensive patient-based approach to compare triptans. Headache 2002, 2(Suppl. 1): 18-25.
8. Gallagher, R.M., Kunkel, R. Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment. Headache 2003, 43: 36-43.
9. Lipton, R.B., Stewart, W.F. Acute migraine therapy: Do doctors understand what patients with migraine want from therapy? Headache 1999, 39: S20-26.